These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 24668112)

  • 1. Use of placebo in a trial of thalidomide for pediatric Crohn disease--reply.
    Lazzerini M; Martelossi S; Ventura A
    JAMA; 2014 Mar; 311(12):1251-2. PubMed ID: 24668112
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of placebo in a trial of thalidomide for pediatric Crohn disease.
    El-Matary W
    JAMA; 2014 Mar; 311(12):1251. PubMed ID: 24668111
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to Thalidomide Treatment of Pediatric Ulcerative Colitis: A New Use for an Old Drug.
    Lazzerini M; Martelossi S; Ventura A
    Inflamm Bowel Dis; 2015 Aug; 21(8):1752-3. PubMed ID: 25993695
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of thalidomide on clinical remission in children and adolescents with refractory Crohn disease: a randomized clinical trial.
    Lazzerini M; Martelossi S; Magazzù G; Pellegrino S; Lucanto MC; Barabino A; Calvi A; Arrigo S; Lionetti P; Lorusso M; Mangiantini F; Fontana M; Zuin G; Palla G; Maggiore G; Bramuzzo M; Pellegrin MC; Maschio M; Villanacci V; Manenti S; Decorti G; De Iudicibus S; Paparazzo R; Montico M; Ventura A
    JAMA; 2013 Nov; 310(20):2164-73. PubMed ID: 24281461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial: is thalidomide a good option for patients with refractory Crohn's disease? Authors' reply.
    Gerich M; Yoon J; Vasiliauskas E
    Aliment Pharmacol Ther; 2015 Apr; 41(8):786. PubMed ID: 25781039
    [No Abstract]   [Full Text] [Related]  

  • 6. Thalidomide Treatment of Pediatric Ulcerative Colitis: A New Use for an Old Drug.
    Bousvaros A
    Inflamm Bowel Dis; 2015 Aug; 21(8):1750-1. PubMed ID: 26199988
    [No Abstract]   [Full Text] [Related]  

  • 7. Thalidomide and refractory Crohn's disease: what is in the future?
    Ng SC
    J Clin Gastroenterol; 2014 Jul; 48(6):476-7. PubMed ID: 24781387
    [No Abstract]   [Full Text] [Related]  

  • 8. Thalidomide for Crohn's disease.
    Fishman SJ; Feins NR; D'Amoto RJ; Folkman J
    Gastroenterology; 2000 Aug; 119(2):596. PubMed ID: 10960273
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial: is thalidomide a good option for patients with refractory Crohn's disease?
    Rogler G
    Aliment Pharmacol Ther; 2015 Apr; 41(8):785-6. PubMed ID: 25781038
    [No Abstract]   [Full Text] [Related]  

  • 10. Thalidomide in oral Crohn's disease refractory to conventional medical treatment.
    Odeka EB; Miller V
    J Pediatr Gastroenterol Nutr; 1997 Aug; 25(2):250-1. PubMed ID: 9252926
    [No Abstract]   [Full Text] [Related]  

  • 11. Thalidomide improves clinical remission in children with Crohn's disease.
    Harbour S; Brown N
    Arch Dis Child Educ Pract Ed; 2015 Apr; 100(2):111. PubMed ID: 25721487
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of long-term treatment with thalidomide in children and young adults with Crohn disease: preliminary results.
    Facchini S; Candusso M; Martelossi S; Liubich M; Panfili E; Ventura A
    J Pediatr Gastroenterol Nutr; 2001 Feb; 32(2):178-81. PubMed ID: 11321389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness and security of thalidomide for gastrointestinal bleeding and severe Crohn's disease in children].
    Bauditz J
    Z Gastroenterol; 2014 Oct; 52(10):1198-201. PubMed ID: 25313632
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: Disappearance of Crohn's ulcers in the terminal ileum after thalidomide therapy. Can J Gastroenterol 2004; 18(2): 101-104.
    Cohen LB
    Can J Gastroenterol; 2004 Jun; 18(6):419; author reply 419. PubMed ID: 15230268
    [No Abstract]   [Full Text] [Related]  

  • 15. Thalidomide induces mucosal healing in postoperative Crohn disease endoscopic recurrence: Case report and literature review.
    Hu H; Wang X; Liu S
    Medicine (Baltimore); 2016 Sep; 95(36):e4799. PubMed ID: 27603389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful use of thalidomide for refractory esophageal Crohn's disease.
    Barkin JA; Schonfeld WB; Deshpande AR
    Am J Gastroenterol; 2013 May; 108(5):855-7. PubMed ID: 23644969
    [No Abstract]   [Full Text] [Related]  

  • 17. Thalidomide for Crohn's disease: high dose, low dose, or "no doze" at all?
    Katz JA
    Inflamm Bowel Dis; 2000 May; 6(2):152-3. PubMed ID: 10833076
    [No Abstract]   [Full Text] [Related]  

  • 18. Disappearance of Crohn's ulcers in the terminal ileum after thalidomide therapy.
    Hershfield NB
    Can J Gastroenterol; 2004 Feb; 18(2):101-4. PubMed ID: 14997219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalidomide in refractory vulvar ulcerations associated with Crohn's disease.
    Kolivras A; De Maubeuge J; André J; Song M
    Dermatology; 2003; 206(4):381-3. PubMed ID: 12771492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thalidomide use and outcomes in pediatric patients with Crohn disease refractory to infliximab and adalimumab.
    Felipez LM; Gokhale R; Tierney MP; Kirschner BS
    J Pediatr Gastroenterol Nutr; 2012 Jan; 54(1):28-33. PubMed ID: 21681114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.